Cargando…
CXCR3 Signaling in BRAF(WT) Melanoma Increases IL-8 Expression and Tumorigenicity
Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in me...
Autores principales: | Jenkins, Molly H., Brinckerhoff, Constance E., Mullins, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370421/ https://www.ncbi.nlm.nih.gov/pubmed/25798946 http://dx.doi.org/10.1371/journal.pone.0121140 |
Ejemplares similares
-
The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
por: Jenkins, Molly H., et al.
Publicado: (2015) -
A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model
por: Bellmann, Lydia, et al.
Publicado: (2019) -
BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
por: Whipple, C A, et al.
Publicado: (2014) -
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
por: Hasan, Tanwir, et al.
Publicado: (2019) -
A Matrix Metalloproteinase-1/Protease Activated Receptor-1 signaling axis promotes melanoma invasion and metastasis
por: Blackburn, Jessica S., et al.
Publicado: (2009)